BIOMAT Database Logo BIOMAT Database Logo

Mode of action of the cytostatic agent "ICRF 159". 1970

H B Sharpe, and E O Field, and K Hellmann

UI MeSH Term Description Entries
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008938 Mitosis A type of CELL NUCLEUS division by means of which the two daughter nuclei normally receive identical complements of the number of CHROMOSOMES of the somatic cells of the species. M Phase, Mitotic,Mitotic M Phase,M Phases, Mitotic,Mitoses,Mitotic M Phases,Phase, Mitotic M,Phases, Mitotic M
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D046508 Culture Techniques Methods of maintaining or growing biological materials in controlled laboratory conditions. These include the cultures of CELLS; TISSUES; organs; or embryo in vitro. Both animal and plant tissues may be cultured by a variety of methods. Cultures may derive from normal or abnormal tissues, and consist of a single cell type or mixed cell types. Culture Technique,Technique, Culture,Techniques, Culture

Related Publications

H B Sharpe, and E O Field, and K Hellmann
[ICRF 159--a cytostatic substance].
October 1978, Deutsche medizinische Wochenschrift (1946),
H B Sharpe, and E O Field, and K Hellmann
Cumulative cytostatic effect of ICRF 159.
February 1974, Nature,
H B Sharpe, and E O Field, and K Hellmann
Proceedings: Analysis of the antimetastatic action of the antimitotic agent ICRF 159.
August 1974, British journal of cancer,
H B Sharpe, and E O Field, and K Hellmann
[Mode of action of the cytostatic agent Cesalin].
August 1977, Hippokrates,
H B Sharpe, and E O Field, and K Hellmann
The mutagenic activity of razoxane (ICRF 159): an anticancer agent.
November 1985, British journal of cancer,
H B Sharpe, and E O Field, and K Hellmann
Editoral: ICRF 159.
March 1974, Lancet (London, England),
H B Sharpe, and E O Field, and K Hellmann
Letter: ICRF 159.
May 1974, Lancet (London, England),
H B Sharpe, and E O Field, and K Hellmann
Letter: ICRF 159.
March 1974, Lancet (London, England),
H B Sharpe, and E O Field, and K Hellmann
A clinical evaluation of ICRF 159 as a radiosensitising agent.
January 1978, International journal of radiation oncology, biology, physics,
H B Sharpe, and E O Field, and K Hellmann
The bioavailability in man of ICRF-159 a new oral antineoplastic agent.
December 1975, The Journal of pharmacy and pharmacology,
Copied contents to your clipboard!